APA način citiranja (7. izdanje)

Satsangi, J., Simmons, J., Marshall, S., Mitchell, S., Chapman, R., Welsh, K., & Jewell, D. (2000). CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.

Čikaški stil citiranja (17. izdanje)

Satsangi, J., J. Simmons, S. Marshall, S. Mitchell, R. Chapman, K. Welsh, i D. Jewell. CCR5 Delta 32 Polymorphism in Inflammatory Bowel Disease: Further Association with Ulcerative Colitis and with Primary Sclerosing Cholangitis. 2000.

MLA način citiranja (9. izdanje)

Satsangi, J., et al. CCR5 Delta 32 Polymorphism in Inflammatory Bowel Disease: Further Association with Ulcerative Colitis and with Primary Sclerosing Cholangitis. 2000.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.